Mesa Laboratories Inc (MLAB) stock
MLABNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3071% above fair value
$135.20−4.01 (-2.88%)
Close on Nov 12, 2026Market cap $756.56MP/E 117.6Yield 0.47%
Mesa Laboratories ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Mesa Laboratories's ebitda for the twelve months ending Sep 30, 2023 was $37.06M, down 16.6% year over year. For fiscal 2023 it was $37.14M, up 24.8% from the year before. Over ten years it grew 8.4% a year on average. The highest annual figure on record is $37.14M in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | $37.14M | +24.8% |
| FY2022 | Mar 31, 2022 | $29.77M | -0.8% |
| FY2021 | Mar 31, 2021 | $30.02M | +43.5% |
| FY2020 | Mar 31, 2020 | $20.91M | +8.9% |
| FY2019 | Mar 31, 2019 | $19.21M | +64.8% |
| FY2018 | Mar 31, 2018 | $11.65M | -53.5% |
| FY2017 | Mar 31, 2017 | $25.05M | +6.6% |
| FY2016 | Mar 31, 2016 | $23.50M | +9.2% |
| FY2015 | Mar 31, 2015 | $21.52M | +37.7% |
| FY2014 | Mar 31, 2014 | $15.63M | -5.5% |
| FY2013 | Mar 31, 2013 | $16.54M | +12.6% |
| FY2012 | Mar 31, 2012 | $14.69M | +25.5% |
| FY2011 | Mar 31, 2011 | $11.71M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $8.04M | -33.3% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $7.47M | +111.0% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $9.57M | -60.9% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $11.98M | +177.0% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $12.05M | +42.1% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $3.54M | -54.0% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $24.50M | +58.3% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $4.33M | -6.4% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $8.48M | -4.7% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $7.70M | +2.9% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $15.47M | +137.5% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $4.62M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $8.90M | +27.9% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $7.48M | -1.3% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $6.52M | +35.0% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$198.00K | -105.5% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $6.96M | +94.8% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $7.57M | +4.9% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $4.83M | -47.2% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $3.59M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $3.57M | -39.5% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $7.22M | +69.5% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $9.13M | +22.3% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$7.64M | -216.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $5.90M | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $4.26M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $7.47M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $6.58M | – |
See a number that looks wrong?